- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06124664
Study of Venous Outflow From the Lower Limbs in Patients With Pelvic Varicosities
Study of Venous Outflow From the Lower Limbs in Patients With Pelvic Varicosities as a New Strategy for Compression Treatment of Pelvic Varicose Veins and Varicose Veins of the Lower Limb
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a single-center, prospective, comparative cohort study. The duration of the study is from 4/5/2023 to 1/12/2023. The study will include 90 patients (40 patients with symptomatic PVV without CVD, 40 patients with asymptomatic PVV and symptoms of CVD, 10 patients with CVD of the lower limb without PVV.
Currently, the term "varicose veins" implies not only the pathology of the superficial veins of the lower limbs, but also the pelvic veins. As yet, no epidemiological studies have investigated the frequency of the combination of pelvic and lower limb varicose veins, but in some studies the authors point to a combination of lower limb varicose veins and pelvic varicose veins (PVV) in 30-60% of patients. In this scenario, we are discussing the disease's clinically manifested forms, where lower limb varicose veins are visually identified and pelvic veins are identified by ultrasound and manifest as symptoms of pelvic congestion syndrome. There is no evidence of a concomitant occurrence of asymptomatic or latent forms of varicose veins in the lower limbs and PVV. (In this cases during duplex ultrasound angioscanning (DUS), pathological blood reflux is detected in the dilated superficial veins of the lower limbs and pelvis. However, there are no symptoms or signs of the disease.) As a result, it is not possible to assess the true prevalence of the combination of CVD and PVV.
At the same time, it is evident that dilatation and reflux in pelvic veins cannot but affect the clinical course of CVD in general and lower limb varicose vein disease in particular. Multiple studies from our clinic and foreign colleagues have substantiated this claim. It is caused not only by anatomical links between pelvic veins and lower limbs (perineal, clitoral perforating veins, tributaries of internal iliac veins), but also by common triggering mechanisms and similar pathogenesis of lower limb varicose vein disease and PVV.
Considering the above, valid questions arise about the effect of pelvic varicose veins with reflux on lower extremity venous outflow:
- How does asymptomatic pelvic vein dilation with reflux impact venous outflow from the lower extremities and the clinical manifestations of CVD?
- Does symptomatic pelvic vein dilation with reflux affect venous outflow from the lower limbs and clinical manifestations of CVD?
- Does vulvar vein dilation affect venous outflow from the lower limbs and CVD clinical manifestations?
- Is the severity or exposure of pelvic congestion syndrome a predictor for the development of lower limb venous outflow disorders?
- How does the severity of clinical manifestations of PCS correspond to the severity of hemodynamic disturbance, as determined through instrumental research methods?
These questions have significance not only in academic and scientific domains. They are directly related to the strategy and tactics of treating patients with a combination of varicose veins of lower limbs and PVV, PCS and CVD, since the following fundamental issues have not yet been resolved:
- Do asymptomatic patients with instrumental detection of PVV and lower limb varicose vein require correction?
- Is it appropriate to utilize compression knitwear in patients with an asymptomatic course of instrumentally confirmed venous outflow disorders with a combination of pelvic and lower extremity varicose veins?
- Can the coefficient of pelvic venous congestion be utilized as a quantitative indicator to prescribe compression treatment for venous outflow disorders in the lower limbs of asymptomatic patients without signs of CVD? In other words, can the coefficient of pelvic venous congestion be used as a reference index for correcting the evacuative function of the tibial MVP in patients without clinical manifestations of CVD?
- How effective is compression in correcting impaired venous outflow from the lower limbs in PVV patients? The severity of the clinical course of lower limb CPV is determined by objective symptoms such as pain, edema, trophic disorders, and venous ulceration. In patients with CVD, the severity of the disease course determines the development of pelvic congestion syndrome (PCS), which is manifested by chronic pelvic pain (CPP), hypogastric heaviness, and dyspareunia. CPP and dyspareunia are the main indicators of the severity of the clinical course of PCS. It has been demonstrated that PCS exacerbates the symptoms of CVD. Thus, correlating the severity of pelvic pain to the degree of pelvic venous fullness (coefficient calculated by pelvic venous scintigraphy) allows us to assume the presence of venous outflow disorders of the lower extremities. According to this hypothesis, the presence and severity of venous outflow disorders of the lower limbs can be determined not only by the results of instrumental examination of the pelvic and limb veins, but also by clinical assessment of the severity of CPP.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Sergey G Gavrilov, MD, PhD
- Phone Number: +79169299947
- Email: gavriloffsg@mail.ru
Study Contact Backup
- Name: Anatoly V Karalkin, MD, PhD
- Phone Number: +79166196821
- Email: avkrar@list.ru
Study Locations
-
-
-
Moskva, Russian Federation, 119049
- Recruiting
- Ananstsia Grishenkova
-
Contact:
- Ananstsia S Grishenkova, PhD
- Phone Number: +79162851112
- Email: ngrishenkova@rambler.ru
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patient age from 18 to 40 years;
- Presence of pelvic varicose veins according to DUS data;
- Reflux in the pelvic veins for more than 1 second before this DUS;
- Reflux in the superficial veins of the lower limbs.
Exclusion Criteria:
- Menopause;
- Pregnancy;
- Postthrombotic disease;
- Suspicion of May-Turner syndrome;
- Ultrasound signs of nutcracker syndrome
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Symptomatic pelvic varicose veins (PVV)
40 patients will include patients with symptomatic PVV (pelvic pain, dyspareunia, heaviness in the hypogastrium) and without symptoms and signs of CVD.
|
With the patient in an upright position, 370 MBq of 99mTc pertechnetate is injected into one of the dorsal veins of the foot after applying a tourniquet in the area of the ankle joint.
Then, with the help of a gamma camera detector, the movement of the radiopharmaceutical is monitored in the following segments: tibial (muscular-venous pump of the lower leg), popliteal, femoral and iliocaval.
To study the evacuation function of the muscular-venous pump (MVP) of the leg, using an analytical computer program, areas of interest are identified in the tendon, muscle parts of the veins of the leg and the popliteal vein.
The time of evacuation of the radiopharmaceutical from the MVP of the leg is estimated - the average transport time of the isotope.
SPECT of the pelvic veins with in vivo-labelled red blood cells (RBCs).
For radionuclide assessment of the state of the pelvic veins, 2 ml of Perfotech solution is injected into the cubital vein for subsequent "labeling" of red blood cells in vivo.
In 20 minutes.
370 MBq of 99mTc-pertechnetate is injected into one of the veins of the dorsum of the foot and radionuclide venoscintigraphy is performed according to the method presented above.
20 minutes after the administration of the radiopharmaceutical and the venography, SPECT of the pelvic veins is performed.
Tomography of the distribution of labeled erythrocytes in the pelvic veins is carried out in a circular orbit with the gamma camera detector rotated 360°.
The analysis of the obtained information is carried out using the standard ECT Protocol software package, which allows obtaining sections in 3 projections (sagittal, transversal and coronal) with a slice step of 8 mm.
|
Asymptomatic PVV
40 pdtients will consist of women with asymptomatic PVV with signs of CVD.
|
With the patient in an upright position, 370 MBq of 99mTc pertechnetate is injected into one of the dorsal veins of the foot after applying a tourniquet in the area of the ankle joint.
Then, with the help of a gamma camera detector, the movement of the radiopharmaceutical is monitored in the following segments: tibial (muscular-venous pump of the lower leg), popliteal, femoral and iliocaval.
To study the evacuation function of the muscular-venous pump (MVP) of the leg, using an analytical computer program, areas of interest are identified in the tendon, muscle parts of the veins of the leg and the popliteal vein.
The time of evacuation of the radiopharmaceutical from the MVP of the leg is estimated - the average transport time of the isotope.
SPECT of the pelvic veins with in vivo-labelled red blood cells (RBCs).
For radionuclide assessment of the state of the pelvic veins, 2 ml of Perfotech solution is injected into the cubital vein for subsequent "labeling" of red blood cells in vivo.
In 20 minutes.
370 MBq of 99mTc-pertechnetate is injected into one of the veins of the dorsum of the foot and radionuclide venoscintigraphy is performed according to the method presented above.
20 minutes after the administration of the radiopharmaceutical and the venography, SPECT of the pelvic veins is performed.
Tomography of the distribution of labeled erythrocytes in the pelvic veins is carried out in a circular orbit with the gamma camera detector rotated 360°.
The analysis of the obtained information is carried out using the standard ECT Protocol software package, which allows obtaining sections in 3 projections (sagittal, transversal and coronal) with a slice step of 8 mm.
|
varicose veins of the lower limb
10 patients with varicose veins of the lower limb without PVV and pelvic congestion syndrome (PCS)
|
With the patient in an upright position, 370 MBq of 99mTc pertechnetate is injected into one of the dorsal veins of the foot after applying a tourniquet in the area of the ankle joint.
Then, with the help of a gamma camera detector, the movement of the radiopharmaceutical is monitored in the following segments: tibial (muscular-venous pump of the lower leg), popliteal, femoral and iliocaval.
To study the evacuation function of the muscular-venous pump (MVP) of the leg, using an analytical computer program, areas of interest are identified in the tendon, muscle parts of the veins of the leg and the popliteal vein.
The time of evacuation of the radiopharmaceutical from the MVP of the leg is estimated - the average transport time of the isotope.
SPECT of the pelvic veins with in vivo-labelled red blood cells (RBCs).
For radionuclide assessment of the state of the pelvic veins, 2 ml of Perfotech solution is injected into the cubital vein for subsequent "labeling" of red blood cells in vivo.
In 20 minutes.
370 MBq of 99mTc-pertechnetate is injected into one of the veins of the dorsum of the foot and radionuclide venoscintigraphy is performed according to the method presented above.
20 minutes after the administration of the radiopharmaceutical and the venography, SPECT of the pelvic veins is performed.
Tomography of the distribution of labeled erythrocytes in the pelvic veins is carried out in a circular orbit with the gamma camera detector rotated 360°.
The analysis of the obtained information is carried out using the standard ECT Protocol software package, which allows obtaining sections in 3 projections (sagittal, transversal and coronal) with a slice step of 8 mm.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The average transport time of the isotope
Time Frame: Day 0 and Day 10
|
Average transport time of the isotope is a value inversely proportional to the volumetric velocity of blood flow.
The greater the average transport time of the isotope, the slower the speed of blood flow through the deep veins of the leg and vice versa.
In addition, the linear speed of blood flow through the tibial veins is calculated.
The data obtained allow us to judge the function of the MVP of the lower leg.
|
Day 0 and Day 10
|
coefficient of the pelvic venous congestion
Time Frame: Day 0
|
The computer equipment of the gamma camera allows you to calculate the number of pulses from the area of interest.
The radiopharmaceutical radiation activity is recorded by the gamma camera in pulses per second.
Pulse per second is a quantitative expression of the content of labeled red blood cells in the area of interest.
Taking into account the different speed of blood flow in the pelvic veins in different patients and in order to objectify the data obtained, the ratio of pulse counts from 2 standard areas of interest is used - the veins of the uterus and parametrium and the common iliac vein on either side.
This ratio is called coefficient of the pelvic venous congestion(Сpvc).
The activity of labeled erythrocytes in this vessel is the most stable value.
The activity of erythrocyte-phosphate-pertechnetate complexes in the venous plexuses depends on the presence of their varicose transformation and the deposition of blood in them.
|
Day 0
|
Collaborators and Investigators
Investigators
- Study Chair: Natalia V Koroleva, PhD, Pirogov Russian National Research Medical University
Publications and helpful links
General Publications
- Partsch H. Compression for the management of venous leg ulcers: which material do we have? Phlebology. 2014 May;29(1 suppl):140-145. doi: 10.1177/0268355514528129. Epub 2014 May 19.
- Vin F, Benigni JP; International Union of Phlebology; Bureau de Normalisation des Industries Textiles et de l'Habillement; Agence Nationale d'Accreditation et d'Evaluation en Sante. Compression therapy. International Consensus Document Guidelines according to scientific evidence. Int Angiol. 2004 Dec;23(4):317-45. No abstract available.
- Nicolaides A, Kakkos S, Eklof B, Perrin M, Nelzen O, Neglen P, Partsch H, Rybak Z. Management of chronic venous disorders of the lower limbs - guidelines according to scientific evidence. Int Angiol. 2014 Apr;33(2):87-208. No abstract available.
- Gavrilov SG, Karalkin AV, Turischeva OO. Compression treatment of pelvic congestion syndrome. Phlebology. 2018 Jul;33(6):418-424. doi: 10.1177/0268355517717424. Epub 2017 Jun 22.
- Gultasli NZ, Kurt A, Ipek A, Gumus M, Yazicioglu KR, Dilmen G, Tas I. The relation between pelvic varicose veins, chronic pelvic pain and lower extremity venous insufficiency in women. Diagn Interv Radiol. 2006 Mar;12(1):34-8.
- Whiteley AM, Taylor DC, Dos Santos SJ, Whiteley MS. Pelvic venous reflux is a major contributory cause of recurrent varicose veins in more than a quarter of women. J Vasc Surg Venous Lymphat Disord. 2014 Oct;2(4):411-5. doi: 10.1016/j.jvsv.2014.05.005. Epub 2014 Jun 24.
- Bora A, Avcu S, Arslan H, Adali E, Bulut MD. The relation between pelvic varicose veins and lower extremity venous insufficiency in women with chronic pelvic pain. JBR-BTR. 2012 Jul-Aug;95(4):215-21. doi: 10.5334/jbr-btr.623.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 012012548112
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Varicose Veins of Lower Limb
-
I-VASC S.r.lRecruiting
-
Acotec Scientific Co., LtdZhejiang UniversityCompletedVaricose Veins of Lower LimbChina
-
Beijing Tsinghua Chang Gung HospitalActive, not recruiting
-
Oulu University HospitalCompletedVaricose Veins | Varicose Veins of Lower LimbFinland
-
The Fourth Affiliated Hospital of Zhejiang University...RecruitingVaricose Veins of Lower LimbChina
-
Worcestershire Acute Hospitals NHS TrustCompletedVaricose Veins of Lower LimbUnited Kingdom
-
Pirogov Russian National Research Medical UniversityCompletedVaricose Veins | Varicose Veins of Lower LimbRussian Federation
-
Helsinki University Central HospitalCompletedVaricose Veins of Lower Limb
-
Societe Francaise de PhlebologieCompletedVaricose Veins of Lower Limb
-
The University of Hong Kong-Shenzhen HospitalUnknown
Clinical Trials on Radionuclide venography
-
Xuanwu Hospital, BeijingThe People Hospital of Baoan ShenzhenActive, not recruitingArterial AneurysmChina
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Multiple Sclerosis Society of...Completed
-
Sohag UniversityRecruitingAnatomical Variants of Dural Sinuses by Magnetic Resonance VenographyEgypt
-
Assistance Publique - Hôpitaux de ParisCompletedPulmonary ThromboembolismFrance
-
Weill Medical College of Cornell UniversityPenumbra Inc.; Society of Interventional Radiology Foundation; VIVA Physicians; Foundation for Venous and Lymphatic MedicineNot yet recruitingPelvic Pain | Chronic Pelvic Pain Syndrome | Pelvic Pain Syndrome | Pelvic Congestive Syndrome | Pelvic VaricesUnited States
-
S. Anna HospitalRegione Emilia-RomagnaCompletedMultiple Sclerosis | Venous InsufficiencyItaly
-
Maastricht University Medical CenterUnknown
-
Assiut UniversityUnknownHemodialysis Access Failure
-
George Washington UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedLung Diseases | Pulmonary EmbolismUnited States, Canada
-
Assiut UniversityUnknown